Home > SWOT Analysis > Valeant Pharma (VRX) SWOT Analysis

Valeant Pharma (VRX) SWOT Analysis Profile

Valeant Pharmaceuticals International, founded in 1960, develops, manufactures, and markets specialty pharmaceutical products. It primarily offers prescription pharmaceutical products in the areas of neurology, dermatology, and infectious diseases. It also provides products in the areas of neuromuscular disorders, cancer, cardiovascular disease, diabetes, and psychiatric disorders, and produces a skin care line for various skin disorders. Headquartered in Aliso Viego, California, the company markets its hundreds of branded products to physicians, hospitals, pharmacies, and wholesalers in the United States and abroad. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 8

Threats + Weaknesses = 6

… A history of overcoming weaknesses makes it difficult for other firms to exploit their difficulties. The ability to capitalize on opportunities get rewarded with higher profits and lower costs.